⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Silicate Bioceramics (Silicate Anti-Senescence / ZnCS)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-04-02 — Ceramic-based biomaterials: Combining regeneration with anti-senescence.: Preclinical osteoporotic bone regeneration study: hardystonite (ZnCS) silicate bioceramics released Zn and silicate ions that delayed BMSC senescence via PI3K–AKT–SIRT1 signaling and accelerated bone regeneration, reportedly outperforming systemic dasatinib+quercetin in head-to-head preclinical comparison — first explicit framing of silicate bioceramics as an intrinsic ‘silicate anti-senescence’ (SAS) modality. [animal-model] (novelty: 4)
Open questions
Related
Contributing findings
Ceramic-based biomaterials: Combining regeneration with anti-senescence.
02-apr-2026
novelty 4
per-area 4
strengthens